rss
Mol Path 55:177-181 doi:10.1136/mp.55.3.177
  • Original Article

Limitations of the use of single base changes in the p53 gene to detect minimal residual disease of breast cancer

Table 3

Optimised ARMS conditions for 11 tumours and the T47D cell line with a p53 mutation

Patient/cell line 3′ mismatch 2nd mismatch Product size Ta (°C) Mg conc. (mM) No. of PCR cycles
*ARMS failed to optimise.
ARMS, amplification refractory mutation system; Ta, annealing temperature.
T47D T–G A–A 127 bp 64 1.75 35
B3 A–G A–A 87 bp 64 2 35
B11 G–T C–T 140 bp 67 1.5 35
B16 G–G C–C 130 bp 64 2 35
B27 A–C A–G 143 bp 60 2 35
B28* G–T G–G 78 bp
B30 T–C C–C 115 bp 56 2 35
B33* G–T G–G 78 bp
B37 A–C C–T 112 bp 69 1.75 33
B45 T–G C–C 125 bp 60 1.75 35
B46* A–G C–T 170 bp
B50* G–T T–C 170 bp

This Article

  • Pathology jobs

    Pathology jobs